Logan Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-405,555
Closed -$10.8M 464
2025
Q4
$10.1M Sell
405,555
-51,996
-11% -$1.31M 0.43% 66
2025
Q3
$11.7M Buy
457,551
+20,303
+5% +$501K 0.49% 56
2025
Q2
$10.6M Sell
437,248
-164,914
-27% -$3.85M 0.49% 57
2025
Q1
$15.3M Buy
602,162
+76,174
+14% +$1.99M 0.69% 41
2024
Q4
$14M Sell
525,988
-54,557
-9% -$1.48M 0.58% 47
2024
Q3
$16.8M Buy
580,545
+15,160
+3% +$442K 0.69% 40
2024
Q2
$15.8M Sell
565,385
-8,502
-1% -$234K 0.68% 38
2024
Q1
$15.9M Buy
573,887
+123,878
+28% +$3.44M 0.68% 40
2023
Q4
$13M Sell
450,009
-38,448
-8% -$1.16M 0.6% 48
2023
Q3
$16.2M Buy
488,457
+44,067
+10% +$1.56M 0.82% 30
2023
Q2
$16.3M Buy
444,390
+13,701
+3% +$533K 0.78% 34
2023
Q1
$17.6M Buy
430,689
+23,334
+6% +$1.01M 0.85% 32
2022
Q4
$20.9M Sell
407,355
-585
-0.1% -$28K 1.07% 19
2022
Q3
$17.9M Buy
407,940
+3,206
+0.8% +$156K 1.07% 23
2022
Q2
$21.2M Sell
404,734
-9,698
-2% -$494K 1.22% 14
2022
Q1
$21.5M Sell
414,432
-47,022
-10% -$2.44M 1.04% 22
2021
Q4
$27.2M Sell
461,454
-12,850
-3% -$637K 1.18% 20
2021
Q3
$20.4M Buy
474,304
+42,005
+10% +$1.86M 0.95% 27
2021
Q2
$16.9M Sell
432,299
-4,561
-1% -$177K 0.79% 32
2021
Q1
$15.8M Sell
436,860
-1,425
-0.3% -$50.6K 0.79% 33
2020
Q4
$16.1M Sell
438,285
-70,334
-14% -$2.58M 0.81% 32
2020
Q3
$17.7M Sell
508,619
-14,734
-3% -$517K 0.96% 22
2020
Q2
$16.2M Buy
523,353
+10,985
+2% +$373K 0.94% 29
2020
Q1
$15.9M Sell
512,368
-5,311
-1% -$181K 1.11% 24
2019
Q4
$19.2M Buy
517,679
+31,732
+7% +$1.13M 1.05% 26
2019
Q3
$16.6M Buy
485,947
+654
+0.1% +$23.8K 0.98% 31
2019
Q2
$19.9M Buy
485,293
+867
+0.2% +$34.4K 1.17% 23
2019
Q1
$19.5M Sell
484,426
-12,025
-2% -$482K 1.2% 22
2018
Q4
$20.6M Sell
496,451
-42,429
-8% -$1.76M 1.62% 12
2018
Q3
$22.5M Buy
538,880
+353
+0.1% +$13.6K 1.48% 18
2018
Q2
$18.5M Sell
538,527
-2,031
-0.4% -$69.4K 1.29% 22
2018
Q1
$18.2M Buy
540,558
+5,788
+1% +$199K 1.28% 24
2017
Q4
$18.4M Sell
534,770
-18,165
-3% -$619K 1.29% 24
2017
Q3
$18.7M Buy
552,935
+1,287
+0.2% +$41.4K 1.34% 26
2017
Q2
$17.6M Buy
551,648
+18,769
+4% +$592K 1.31% 26
2017
Q1
$17.3M Buy
532,879
+16,865
+3% +$532K 1.33% 24
2016
Q4
$15.9M Buy
516,014
+9,882
+2% +$302K 1.28% 25
2016
Q3
$16.3M Sell
506,132
-315
-0.1% -$10.5K 1.33% 23
2016
Q2
$16.9M Sell
506,447
-132,850
-21% -$4.24M 1.43% 22
2016
Q1
$18M Buy
639,297
+89,843
+16% +$2.57M 1.45% 20
2015
Q4
$16.8M Buy
549,454
+2,071
+0.4% +$65.2K 1.34% 23
2015
Q3
$16.3M Sell
547,383
-25,042
-4% -$803K 1.36% 20
2015
Q2
$18.2M Sell
572,425
-69,473
-11% -$2.26M 1.34% 19
2015
Q1
$21.2M Sell
641,898
-12,049
-2% -$383K 1.49% 15
2014
Q4
$19.3M Sell
653,947
-30,466
-4% -$874K 1.4% 19
2014
Q3
$19.2M Buy
684,413
+9,757
+1% +$274K 1.38% 23
2014
Q2
$19M Buy
674,656
+25,124
+4% +$716K 1.34% 25
2014
Q1
$19.8M Sell
649,532
-9,761
-1% -$291K 1.43% 19
2013
Q4
$19.2M Buy
659,293
+54,207
+9% +$1.58M 1.36% 23
2013
Q3
$16.5M Buy
605,086
+36,485
+6% +$993K 1.23% 27
2013
Q2
$12.4M Buy
+568,601
New +$15.7M 1% 41

Other funds holding PFE

Logan Capital Management's PFE Position: Q1 2026 in Review

Logan Capital Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 405,555 shares — an estimated $10.8M sold.

Logan Capital Management first reported a position in PFE in Q2 2013 and held it in 51 quarters. The position peaked at $27.2M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Logan Capital Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Logan Capital Management sold 405,555 Pfizer shares in Q1 2026, an estimated $10.8M.
  • Logan Capital Management first reported a position in Pfizer in Q2 2013 and held it in 51 quarters.
  • Logan Capital Management's Pfizer position peaked at $27.2M in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.